Skip to main content
. 2013 May;68(5):638–643. doi: 10.6061/clinics/2013(05)010

Figure 1.

Figure 1

High-grade ductal carcinoma in situ (DCIS) (A) showing positive membranous-cytoplasmic immunostaining for basal cytokeratin (CK 5/6) (B); and low-grade DCIS (C) showing positive membranous-cytoplasmic immunostaining for CK 5/6 (D) (original magnification 100X).